I am guilty of buying at the ask multiple times (not this week) to keep us treading water. I feel the same way as you. I realized the share price can appreciate or be kept from depreciating sometimes 10% by buying at the ask no matter if it was 100 shares or a 1000 shares. Remember I said I have been adding to my shares which actually lowered my cost basis over the past 4 years. I am content knowing this was not too good to be true as far as the science goes and I seriously have enough knowledge about the company that we will absolutely succeed. IMO, this is a screaming buy. Anyone selling will be telling the story we all have heard or experienced ourselves about the time I coulda, woulda, shoulda. I am excited about each day now that we are validated once again. It was like we were labeled doomed for failure or a scam. But over and over Dr Moro continues to silence the nay sayers. This is how many companies become household names. Once we have a product launched, which now will be in hyperdrive thanks to our newest(but not last)licensee. It will cause any other potential licensees (and I hear there are many playing with Recaf now) that will feel that they are missing out on a monster money maker. They won't want to be the last ship to leave port.
I can't help being frustrated with the share price, but if we close up 10% a day I shouldn't bit*h. This is and will continue to be volatile till BioCurex launches its Recaf. I wonder if Abbott is sneaky enough to launch outside the US? We have all been fixated on the US and they are a multinational company. They could be sly enough to get european approval first. That way when anyone is searching the databases for any filings we would be looking up the wrong tree. That would be sweet! I doubt it, but you never know.
